Devbhumi Pharmaceutical Analytical Testing And Training Foundation Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 2 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Devbhumi Pharmaceutical Analytical Testing And Training Foundation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Archit Virmani, Ashwani Garg, and Anil Sharma serve as directors at the Company.
- CIN/LLPIN
U85300UR2022NPL014618
- Company No.
014618
- Company Classification
Private Not For Profit Company
- Incorporation Date
15 Sep 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Devbhumi Pharmaceutical Analytical Testing And Training Foundation?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archit Virmani  | Director | 29-Mar-2023 | Current |
| Ashwani Garg | Director | 29-Mar-2023 | Current |
| Anil Sharma | Director | 15-Sep-2022 | Current |
Financial Performance of Devbhumi Pharmaceutical Analytical Testing And Training Foundation.
Devbhumi Pharmaceutical Analytical Testing And Training Foundation, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Devbhumi Pharmaceutical Analytical Testing And Training Foundation?
In 2023, Devbhumi Pharmaceutical Analytical Testing And Training Foundation had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Smau International Industry & Trade ChambersInactive For E-Filing 7 months 22 days
Anil Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Devbhumi Pharmaceutical Analytical Testing And Training Foundation?
Devbhumi Pharmaceutical Analytical Testing And Training Foundation has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devbhumi Pharmaceutical Analytical Testing And Training Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devbhumi Pharmaceutical Analytical Testing And Training Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
